Literature DB >> 11274310

Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes.

N Lechtzin1, C M Wiener, L Clawson, V Chaudhry, G B Diette.   

Abstract

OBJECTIVE: As ALS progresses, extensive supportive care is required, including multidisciplinary outpatient care and hospitalization. The authors studied the causes, health care utilization, and outcomes for hospitalized patients with ALS.
METHODS: With use of the 1996 Nationwide Inpatient Sample, an administrative database representing 20% of U.S. hospitals, 1,600 hospitalizations in patients with ALS were identified and compared with 5,364,728 non-ALS hospitalizations.
RESULTS: The most common concurrent diagnoses in patients with ALS were dehydration and malnutrition (574 patients, 36%), pneumonia (507 patients, 32%), and respiratory failure (398 patients, 25%). Only 38% of patients with ALS were discharged to home without home health care compared with 73% of patients with non-ALS. Fifteen percent of patients with ALS died in the hospital compared with 3% of non-ALS patients. The average length of hospital stay and charges were greater for patients with ALS than for non-ALS patients (8.4 days and $19,810 for ALS patients and 5.4 days and $11,924 for non-ALS patients). Mortality was significantly associated with emergency room admission (versus nonemergency admission; OR = 1.60), increasing age (per year; OR = 1.03), respiratory failure (OR = 3.37), and pneumonia (OR = 2.02) (p < 0.01 for all comparisons).
CONCLUSIONS: Patients with ALS have lengthy and costly hospital admissions, a high in-hospital mortality rate, and few routine discharges. Recognition of the issues that precipitate hospitalization may allow development of preventive strategies.

Entities:  

Mesh:

Year:  2001        PMID: 11274310     DOI: 10.1212/wnl.56.6.753

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Advance care planning for patients with amyotrophic lateral sclerosis.

Authors:  Benjamin H Levi; Zachary Simmons; Courtney Hanna; Allyson Brothers; Erik Lehman; Elana Farace; Megan Bain; Renee Stewart; Michael J Green
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-05       Impact factor: 4.092

Review 2.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

Review 3.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

4.  Associations between co-medications and survival in ALS-a cohort study from Austria.

Authors:  Hakan Cetin; Uros Klickovic; Jakob Rath; Gudrun Zulehner; Judith Füzi; Berthold Reichardt; Michael Hagmann; Julia Wanschitz; Wolfgang N Löscher; Eduard Auff; Fritz Zimprich
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 5.  Management of amyotrophic lateral sclerosis.

Authors:  Philippe Corcia; Vincent Meininger
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital.

Authors:  Federica Edith Pisa; Lorenzo Verriello; Laura Deroma; Daniela Drigo; Paolo Bergonzi; Gian Luigi Gigli; Fabio Barbone
Journal:  Eur J Epidemiol       Date:  2009-08-06       Impact factor: 8.082

7.  Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.

Authors:  Poul Jennum; Rikke Ibsen; Stephen Wørlich Pedersen; Jakob Kjellberg
Journal:  J Neurol       Date:  2012-10-27       Impact factor: 4.849

8.  Pattern of Respiratory Deterioration in Sporadic Amyotrophic Lateral Sclerosis According to Onset Lesion by Using Respiratory Function Tests.

Authors:  Dong-Gun Kim; Yoon-Ho Hong; Je-Young Shin; Kwang-Woo Lee; Kyung Seok Park; Seung-Yong Seong; Jung-Joon Sung
Journal:  Exp Neurobiol       Date:  2015-11-04       Impact factor: 3.261

9.  Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study.

Authors:  Federica Edith Pisa; Giancarlo Logroscino; Paolo Giacomelli Battiston; Fabio Barbone
Journal:  BMC Pulm Med       Date:  2016-11-03       Impact factor: 3.317

Review 10.  Developing multidisciplinary clinics for neuromuscular care and research.

Authors:  Sabrina Paganoni; Katie Nicholson; Fawn Leigh; Kathryn Swoboda; David Chad; Kristin Drake; Kellen Haley; Merit Cudkowicz; James D Berry
Journal:  Muscle Nerve       Date:  2017-08-29       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.